This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Adrenocortical Carcinoma

European Multicenter Study on Role of Lymph Node Dissection in Surgical Management of Adrenal Cortical Carcinoma

Sponsored by Fondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Last updated 2 years ago

Study ID

5171

Status

Recruiting

Type

Observational

Placebo

No

Accepting

18-75 Years
18+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 2 years ago

What is this trial about?

This project will evaluate of the number of patients who underwent adrenalectomy for ACC in different European centers using the EUROCRINE® database. The analysis will focus on the extent of lymph nodal dissection (i.e. number of lymph nodes and nodal stations dissected during adrenalectomy). We aim to evaluate the oncologic radicality of surgical treatment and the rate of tumour recurrences after surgery and nodal metastasis related to the stage of the disease and to tumour side (left/right).

What are the participation requirements?

Yes

Inclusion Criteria

Inclusion Criteria: All adult (18 years old and older) patients that underwent surgery with a final histology of adrenocortical carcinoma from 2015 till 2021 - All adult (18 years old and older) patients - underwent surgery - final histology of adrenocortical carcinoma - among European centers that participate in the Eurocrine® database between 2015 and 2021

No

Exclusion Criteria

- Patients <18 years old - Patients with metastatic disease at time of clinical referral

Locations

Location

Status

Recruiting